Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/617
Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants | |
ul Qamar, M Alqahtani, S Alamri, M Chen, L | |
Acceso Abierto | |
Atribución-NoComercial-SinDerivadas | |
Highlights • SARS-CoV-2 3CL pro is conserved, share 99.02% sequence identity with SARS-CoV 3CL pro and together with 12 point-mutations. • Mutations disrupt important hydrogen bonds and alter the receptor binding site of SARS-CoV-2 3CL pro . • Medicinal plants phytochemicals were proved potential anti-COVID-19 druggable candidates. | |
Journal of Pharmaceutical Analysis | |
2020 | |
Preimpreso | |
https://coronavirus.1science.com/item/aac93c166fe3b9058b9d7ea387c1fa18d3fbb0d0 | |
Inglés | |
VIRUS RESPIRATORIOS | |
Aparece en las colecciones: | Artículos científicos |
Cargar archivos:
Fichero | Tamaño | Formato | |
---|---|---|---|
100511.pdf | 3.21 MB | Adobe PDF | Visualizar/Abrir |